Francesca Bruce
@ScripFrancesca
Followers
605
Following
5
Media
0
Statuses
115
I am a senior writer at the Pink Sheet, all views expressed are my own.
Joined April 2010
RT @PharmaPinkSheet: German HTA: Clinical Cancer Registries Could Hold Key To Better Comparative Data For Benefit Assessments. https://t.co/….
0
1
0
Lots of interesting sessions today at the DIA Europe 2022 meeting today, looking forward to more tomorrow. @DrugInfoAssn.
0
0
0
RT @ScripRegMaureen: Take a look at our free-to-view @PharmaPinkSheet report by @ScripFrancesca on the finer points behind the @EMA_News re….
0
1
0
See why investors are concerned about big prices for advanced therapies
0
0
0
RT @ScripRegMaureen: BC province says it's leading Canada by promoting widespread biosimilar use. Re @JanssenGlobal's Remicade, @PharmaPink….
0
1
0
RT @ScripRegNeena: First application from a drug company for joint health economic assessment under new Swedish/Finnish/Norwegian pilot FIN….
0
4
0
RT @ScripRegNeena: EU parliamentary negotiations step up on controversial new regulation for member states to cooperate on HTA. Next vote s….
0
6
0
RT @ScripRegNeena: Europe's CMDh chair Laura Oliveira Santamaria urges industry to tell us the problems you face in meeting the Brexit dead….
0
8
0
RT @ScripRegNeena: EMA tells me there's been a big response to its survey from companies on how they are preparing for Brexit. It has info….
0
8
0
RT @ScripRegNeena: Interesting session on experience with and lessons learned from EMA's 0070 clinical data publication more than one year….
0
3
0
RT @ScripRegMaureen: We need to mitigate medicines #shortages before they happen. Now we're managing them when they happen. That's too late….
0
4
0
RT @ScripRegMaureen: 2017 was very distressing year in UK in terms of #shortages of generic medicines. "Never seen anything like it," says….
0
8
0
RT @ScripRegMaureen: Getting senior @NICEcomms official on board @ABPI_UK is a major deal for the UK trade association. There's not a lot C….
0
4
0
Brazil's IP system could get more challenging for pharma companies
0
2
2
RT @scripanjug: Minister Ananth Kumar says India will persuade docs to follow generic prescription rule and also propagate it.
0
2
0
RT @PharmaPinkSheet: Adaptive Pathways: A Solution For Worried #Payers in Europe 🔓 ➡. via @ScripRegNeena
https://t.….
0
1
0
RT @PharmaScrip: The #ScripAwards is free to enter and open to any research-based #pharmaceutical or #biotech company. .
0
3
0
Advances in digital healthcare and a new law could make Brazil a better place to do clinical research
0
2
0
UK passes new legislation to curb excessive drug pricing
0
1
0